Nu Skin Enterprises Inc. (NYSE:NUS) had its target price raised by analysts at Citigroup Inc. from $66.00 to $69.00 in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Citigroup Inc.’s price objective would indicate a potential upside of 17.19% from the stock’s previous close.

Several other research firms also recently weighed in on NUS. Jefferies Group set a $46.00 price objective on Nu Skin Enterprises and gave the company a “hold” rating in a research note on Monday, July 25th. TheStreet raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Thursday, August 4th. Pivotal Research raised their price objective on Nu Skin Enterprises from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Deutsche Bank AG raised their price objective on Nu Skin Enterprises from $55.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Finally, Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a research note on Tuesday, June 21st. Two analysts have rated the stock with a sell rating, four have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $49.22.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Shares of Nu Skin Enterprises (NYSE:NUS) opened at 58.88 on Wednesday. The stock has a market capitalization of $3.29 billion, a PE ratio of 33.78 and a beta of 1.75. Nu Skin Enterprises has a 12 month low of $23.51 and a 12 month high of $60.87. The company’s 50 day moving average price is $58.18 and its 200 day moving average price is $45.83.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/nu-skin-enterprises-inc-nus-price-target-raised-to-69-00-2.html

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, August 4th. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.01. Nu Skin Enterprises had a return on equity of 18.46% and a net margin of 4.52%. The firm earned $600.05 million during the quarter, compared to the consensus estimate of $578.87 million. During the same period last year, the business posted $0.75 EPS. Nu Skin Enterprises’s quarterly revenue was up 7.2% on a year-over-year basis. Equities analysts anticipate that Nu Skin Enterprises will post $2.88 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Friday, August 26th were given a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a dividend yield of 2.41%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio is currently 81.14%.

Several large investors have recently made changes to their positions in NUS. Metropolitan Life Insurance Co. NY increased its stake in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares in the last quarter. First Quadrant L P CA increased its stake in shares of Nu Skin Enterprises by 0.5% in the second quarter. First Quadrant L P CA now owns 23,323 shares of the company’s stock worth $1,077,000 after buying an additional 123 shares in the last quarter. Amalgamated Bank increased its stake in shares of Nu Skin Enterprises by 6.0% in the second quarter. Amalgamated Bank now owns 7,263 shares of the company’s stock worth $423,000 after buying an additional 414 shares in the last quarter. Paragon Capital Management Ltd increased its stake in shares of Nu Skin Enterprises by 5.5% in the second quarter. Paragon Capital Management Ltd now owns 8,392 shares of the company’s stock worth $388,000 after buying an additional 441 shares in the last quarter. Finally, Americafirst Capital Management LLC increased its stake in shares of Nu Skin Enterprises by 1.0% in the second quarter. Americafirst Capital Management LLC now owns 64,559 shares of the company’s stock worth $2,982,000 after buying an additional 642 shares in the last quarter. 77.08% of the stock is owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.